V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160005199 | 160020611 | 0 | 74 | Curative (C) | 2019-09-16 | 2020-01-24 | GEMCITABINE | N | Y | DOXORUBICIN + IFOSFAMIDE | 100797738 |
| 160010801 | 160020612 | 165 | 64.2 | null | 2018-04-26 | 2018-05-17 | Olaratumab | 02 | null | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 100508709 |
| 160016734 | 160020613 | 0 | 63 | null | 2021-07-18 | 2021-08-17 | VINCRISTINE | N | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100068510 |
| 160016215 | 160020622 | 1.78 | 101 | Palliative (P) | 2018-09-28 | 2018-10-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101711099 |
| 160016447 | 160020623 | 1.7 | 65.4 | Palliative (P) | 2021-07-26 | 2021-08-13 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101003237 |
| 160016749 | 160020624 | 1.67 | 78.75 | Palliative (P) | 2020-05-17 | 2020-05-20 | Bevacizumab | N | N | CARBOPLATIN + PACLITAXEL | 100080250 |
| 160016868 | 160020625 | 1.73 | 69 | null | 2021-09-08 | 2021-10-15 | Bevacizumab | 02 | null | CARBOPLATIN | 101197738 |
| 160005199 | 160020628 | 0 | 40.4 | Curative (C) | 2020-02-07 | 2020-02-09 | Cisplatin 7 day | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 100797738 |
| 160010801 | 160020629 | 1.62 | 0 | Neo-adjuvant (N) | 2017-06-13 | 2018-06-25 | Niraparib | 02 | N | NIRAPARIB | 100508709 |
| 160016734 | 160020630 | 1.14 | 64.7 | null | 2021-03-23 | 2021-08-31 | Vincristine (weekly) | null | null | GEMCITABINE | 100068510 |
| 160015679 | 160020633 | 1.9 | 38.35 | null | 2021-11-12 | 2021-11-14 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100494943 |
| 160016447 | 160020634 | 1.71 | 74.4 | Palliative (P) | 2021-07-22 | 2021-08-29 | Bevacizumab | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101003237 |
| 160016749 | 160020635 | 1.78 | 78.5 | Palliative (P) | 2019-07-08 | 2020-05-26 | Doxorubicin + Olaratumab | N | N | DOXORUBICIN + OLARATUMAB | 100080250 |
| 160016868 | 160020636 | 1.62 | 88.2 | null | 2021-11-24 | 2021-12-13 | Bevacizumab | 02 | null | DOCETAXEL + GEMCITABINE | 101197738 |
| 160005199 | 160020638 | 1.58 | 63.7 | Adjuvant (A) | 2020-02-17 | 2020-02-23 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | GEMCITABINE | 100797738 |
| 160010801 | 160020639 | 1.83 | 61.4 | Palliative (P) | 2018-06-08 | 2018-08-02 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | DICE TRIAL | 100508709 |
| 160016734 | 160020640 | 1.71 | 14.2 | Palliative (P) | 2021-11-26 | 2022-01-15 | Carboplatin + Vinorelbine IV | 02 | N | NEMO TRIAL | 100068510 |
| 160016749 | 160020644 | 1.72 | 90.2 | Palliative (P) | 2020-06-02 | 2020-06-09 | Trabectedin | 02 | N | TRABECTEDIN | 100080250 |
| 160005199 | 160020647 | 1.82 | 101.7 | Neo-adjuvant (N) | 2019-07-27 | 2020-03-23 | Etoposide + Ifosfamide (3 days) | 02 | N | IVA | 100797738 |
| 160016734 | 160020648 | null | null | Palliative (P) | 2021-10-11 | 2022-03-25 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | PEMBROLIZUMAB | 100068510 |
| 160015679 | 160020650 | 1.84 | 61.1 | null | 2022-03-12 | 2022-03-19 | Trabectedin | 02 | null | VINORELBINE | 100494943 |
| 160016749 | 160020651 | 1.83 | 70 | Disease modification (D) | 2017-04-27 | 2020-05-23 | Docetaxel + Gemcitabine with GCSF | 02 | N | DOCETAXEL + GEMCITABINE | 100080250 |
| 160016734 | 160020653 | 1.56 | 70 | null | 2022-03-20 | 2022-05-22 | MELPHALAN + THALIDOMIDE | 02 | null | IRINOTECAN + CISPLATIN + MITOMYCIN | 100068510 |
| 160015679 | 160020654 | 1.9 | 84 | null | 2022-04-20 | 2022-04-28 | Trabectedin | 02 | null | TRABECTEDIN | 100494943 |
| 170000031 | 170000004 | null | null | null | null | 2020-01-18 | null | null | null | HYDROXYCARBAMIDE | 100674607 |
| 170000087 | 170000015 | 1.7 | null | Adjuvant (A) | 2018-07-08 | 2018-08-06 | null | 2 | N | IMATINIB | 100430136 |
| 170000088 | 170000016 | 1.78 | 78.7 | Palliative (P) | 2017-07-31 | 2017-07-31 | null | 02 | N | BACILLUS CALMETTE-GUERIN | 101357146 |
| 170000114 | 170000021 | null | null | null | null | 2018-11-21 | null | null | null | IMATINIB | 101349906 |
| 170000146 | 170000027 | null | null | null | null | 2020-05-20 | null | null | null | PEMBROLIZUMAB | 101011060 |
| 170000193 | 170000032 | 1.7 | 87.6 | null | 2021-12-23 | 2022-01-04 | null | 02 | null | RITUXIMAB | 101646623 |
| 170000387 | 170000065 | null | null | null | null | 2022-01-11 | null | null | null | CVD | 101576926 |
| 170000393 | 170000067 | null | null | null | null | 2020-06-09 | null | null | null | IXAZOMIB + LENALIDOMIDE | 100383237 |
| 170000401 | 170000070 | null | null | null | null | 2021-03-14 | null | null | null | CARBOPLATIN + GEMCITABINE | 100098803 |
| 170000406 | 170000071 | null | null | null | null | 2020-09-18 | null | null | null | ACALABRUTINIB | 100725702 |
| 170000407 | 170000072 | null | null | null | null | 2016-07-25 | null | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100602704 |
| 170000518 | 170000093 | 0 | 57.9 | null | 2020-12-01 | 2020-12-15 | null | 02 | null | BEVACIZUMAB | 101617307 |
| 170000564 | 170000100 | null | null | null | null | 2020-08-18 | null | null | null | LOMUSTINE | 101483809 |
| 170000587 | 170000103 | null | null | null | null | 2016-12-07 | null | null | null | CISPLATIN + ETOPOSIDE | 101369956 |
| 170000593 | 170000105 | null | null | null | null | 2020-07-13 | null | null | null | ABIRATERONE | 100591828 |
| 170000684 | 170000122 | null | null | null | null | 2020-10-12 | null | null | null | BORTEZOMIB | 100098741 |
| 170000778 | 170000142 | null | null | null | null | 2020-08-21 | null | null | null | CARBOPLATIN + PACLITAXEL | 100866472 |
| 170000839 | 170000149 | null | null | null | null | 2019-10-18 | null | null | null | BEVACIZUMAB | 101704546 |
| 170000881 | 170000156 | null | null | null | null | 2016-08-20 | null | null | null | BEVACIZUMAB + CAPE + OXALIPLATIN | 101787623 |
| 170000959 | 170000165 | null | null | null | null | 2018-05-04 | null | null | null | AXITINIB | 100081414 |
| 170000984 | 170000167 | null | null | null | null | 2021-02-05 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100506226 |
| 170001039 | 170000175 | null | null | null | null | 2019-07-03 | null | null | null | CARBOPLATIN + PACLITAXEL | 100473571 |
| 170001126 | 170000184 | null | null | null | null | 2020-05-27 | null | null | null | CHOP R | 101691890 |
| 170001132 | 170000186 | null | null | null | null | 2018-09-15 | null | null | null | EC | 101660000 |
| 170001276 | 170000205 | null | null | null | null | 2018-06-05 | null | null | null | BORTEZOMIB + THALIDOMIDE | 100741318 |
| 170001308 | 170000212 | null | null | null | null | 2018-01-21 | null | null | null | OSIMERTINIB | 101720450 |